Biofrontera, a biopharmaceutical skin care company, has launched a new derma-cosmetic product, Belixos Gel.
The cooling day care gel combines extracts of cinnamon bark, in the active ingredient complex Sepicontrol A5, and Mahonia aquifolium, with Biofrontera's biocolloid technology; it is designed for inflamed, reddened skin and is said to offer ideal care for those with rosacea and acne.
Professor Dr Hermann Lubbert, CEO of Biofrontera, said: “The new Belixos Gel compliments the company's existing derma-cosmetic products, which successfully bring together the benefits of natural ingredients, already recognised for their efficacy, and Biofrontera's innovative biocolloid formulation, effectively delivering excellent cosmetic properties to the skin."
